Related references
Note: Only part of the references are listed.Autoimmune Effects of Lung Cancer Immunotherapy Revealed by Data-Driven Analysis on a Nationwide Cohort
Shihao Yang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective Study
Yuzo Suzuki et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Immunotherapy to treat malignancy in patients with pre-existing autoimmunity
Patrick Boland et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer
Mingjia Li et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
A decade of immune-checkpoint inhibitors in cancer therapy
Caroline Robert
NATURE COMMUNICATIONS (2020)
Pneumonitis Induced by Immune Checkpoint Inhibitors: From Clinical Data to Translational Investigation
Shicong Zhu et al.
FRONTIERS IN ONCOLOGY (2020)
Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer
Bairavi Shankar et al.
JAMA ONCOLOGY (2020)
Association of Preexisting Interstitial Lung Abnormalities With Immune Checkpoint Inhibitor-Induced Interstitial Lung Disease Among Patients With Nonlung Cancers
Kiyofumi Shimoji et al.
JAMA NETWORK OPEN (2020)
The mechanism and risk factors for immune checkpoint inhibitor pneumonitis in non-small cell lung cancer patients
Xiaoyang Zhai et al.
CANCER BIOLOGY & MEDICINE (2020)
Targeting Treg cells in cancer immunotherapy
Atsushi Tanaka et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2019)
The REDCap consortium: Building an international community of software platform partners
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2019)
Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor-related Pneumonitis An Official American Thoracic Society Research Statement
Catherine R. Sears et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
The alveolar immune cell landscape is dysregulated in checkpoint inhibitor pneumonitis
Karthik Suresh et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Standardization of Spirometry 2019 Update An Official American Thoracic Society and European Respiratory Society Technical Statement
Brian L. Graham et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease
Ayodeji Adegunsoye et al.
CHEST (2019)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Preexisting radiological interstitial lung abnormalities are a risk factor for severe radiation pneumonitis in patients with small-cell lung cancer after thoracic radiation therapy
Fangjuan Li et al.
RADIATION ONCOLOGY (2018)
Efficacy and safety of nivolumab in non-small cell lung cancer with preexisting interstitial lung disease
Osamu Kanai et al.
THORACIC CANCER (2018)
Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors
Karthik Suresh et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
Pre-existing pulmonary fibrosis is a risk factor for anti-PD-1-related pneumonitis in patients with non-small cell lung cancer: A retrospective analysis
Teppei Yamaguchi et al.
LUNG CANCER (2018)
The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis
Omkar Desai et al.
FRONTIERS IN MEDICINE (2018)
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy
Jarushka Naidoo et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
PD-1 inhibitors increase the incidence and risk of pneumonitis in cancer patients in a doseindependent manner: a metaanalysis
Jiaying Wu et al.
SCIENTIFIC REPORTS (2017)
Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer
Monica Khunger et al.
CHEST (2017)
Drug-related pneumonitis during mammalian target of rapamycin inhibitor therapy in patients with neuroendocrine tumors: a radiographic pattern-based approach
Mizuki Nishino et al.
EUROPEAN JOURNAL OF CANCER (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Immunotherapy for Lung Cancer: No Longer an Abstract Concept
Kristen A. Marrone et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2016)
Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer A Systematic Review and Meta-analysis
Mizuki Nishino et al.
JAMA ONCOLOGY (2016)
Impact of Preexisting Interstitial Lung Disease on Acute, Extensive Radiation Pneumonitis: Retrospective Analysis of Patients with Lung Cancer
Yuichi Ozawa et al.
PLOS ONE (2015)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Interstitial Lung Disease in Classic and Skin-Predominant Dermatomyositis
Pamela A. Morganroth et al.
ARCHIVES OF DERMATOLOGY (2010)
Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
Paul A. Harris et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2009)
Interstitial lung disease in Japanese patients with lung cancer - A cohort and nested case-control study
Shoji Kudoh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Diagnosing interstitial lung disease: A practical approach to a difficult problem
KR Flaherty et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2001)
Share Paper
